Granite Investment Partners, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Granite Investment Partners, LLC
- $2.32 Billion
- Q2 2024
A detailed history of Granite Investment Partners, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Granite Investment Partners, LLC holds 397,514 shares of AMPH stock, worth $18.5 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
397,514
Previous 352,770
12.68%
Holding current value
$18.5 Million
Previous $15.5 Million
2.65%
% of portfolio
0.68%
Previous 0.61%
Shares
6 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$276 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$124 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$90.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$78.7 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$75.5 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.28B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...